Search

Your search keyword '"Valproic acid -- Usage"' showing total 31 results
Start Over Descriptor "Valproic acid -- Usage" Topic divalproex -- usage
31 results on '"Valproic acid -- Usage"'

1. STATE PUBLIC INSTITUTION PURCHASING AND ACCOUNTING CENTER OF KURGAN REGION invites tenders for For the Supply of Medicinal Products for Medical Use for Social Security Purposes (Valproic Acid) Lot 7

Subjects
Purchasing -- Usage -- Health aspects, Social security -- Usage -- Health aspects, Accounting -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, News, opinion and commentary
Abstract

STATE PUBLIC INSTITUTION PURCHASING AND ACCOUNTING CENTER OF KURGAN REGION, Russian Federation has invited tenders for For the Supply of Medicinal Products for Medical Use for Social Security Purposes (Valproic [...]

Published
2024

2. STATE BUDGETARY INSTITUTION OF HEALTH REGIONAL CHILDREN'S HOSPITAL invites tenders for Delivery of a Drug for Medical Use of Valproic Acid

Subjects
Valproic acid -- Usage, Children -- Health aspects, Divalproex -- Usage, News, opinion and commentary
Abstract

STATE BUDGETARY INSTITUTION OF HEALTH REGIONAL CHILDREN'S HOSPITAL, Russian Federation has invited tenders for Delivery of a Drug for Medical Use of Valproic Acid. Tender Notice No: 0361200014324000052 Deadline: March [...]

Published
2024

3. Supply Of A Medicinal Product For Medical Use - Valproic Acid For Certain Groups Of The Population And Persons Suffering From Certain Diseases Living In The Chelyabinsk Region, In Accordance With Decree Of The Government Of The Chelyabinsk Region Dated De

Subjects
Purchasing departments -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Business, international
Abstract

Tenders are invited for supply of a medicinal product for medical use - valproic acid for certain groups of the population and persons suffering from certain diseases living in the [...]

Published
2023

6. Centralized Supply Of A Drug For Medical Use Of Valproic Acid (epilepsy)

Subjects
Group purchasing organizations -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Epilepsy -- Usage -- Health aspects, Business, international
Abstract

Tenders are invited for centralized supply of a drug for medical use of valproic acid (epilepsy) Major organization : STATE STATE INSTITUTION OF THE TULA REGION 'CENTER FOR PROCUREMENT ORGANIZATION' [...]

Published
2023

7. The Supply Of A Drug For Medical Use-valproic Acid For Certain Groups Of The Population And Persons Suffering From Individual Diseases Living In The Territory Of The Chelyabinsk Region, According To The Decree Of The Government Of The Chelyabinsk Region D

Subjects
Group purchasing organizations -- Reports -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Business, international
Abstract

Tenders are invited for the supply of a drug for medical use-valproic acid for certain groups of the population and persons suffering from individual diseases living in the territory of [...]

Published
2023

8. The Supply Of A Drug For Medical Use-valproic Acid For Certain Groups Of The Population And Persons Suffering From Individual Diseases Living In The Territory Of The Chelyabinsk Region, According To The Decree Of The Government Of The Chelyabinsk Region D

Subjects
Group purchasing organizations -- Reports -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Business, international
Abstract

Tenders are invited for the supply of a drug for medical use-valproic acid for certain groups of the population and persons suffering from individual diseases living in the territory of [...]

Published
2023

9. Scientists Devise Way to Keep Donor Hearts Viable Longer

Author

Thompson, Dennis

Subjects
Surgical research, Surgery, Experimental, Valproic acid -- Usage, Divalproex -- Usage, Preservation of organs, tissues, etc. -- Methods, Heart -- Transplantation, Health
Abstract

Byline: Dennis Thompson HealthDay Reporter THURSDAY, Feb. 9, 2023 (HealthDay News) -- Doctors have discovered a way to extend the short shelf life of donor hearts, which could hopefully make [...]

Published
2023

10. Study Findings on Public Health Are Outlined in Reports from Jilin University (YouTube as a source of information on preventing the use of valproic acid in women during pregnancy)

Subjects
Valproic acid -- Usage, Public health -- Usage, Divalproex -- Usage, Pregnant women -- Usage, Health
Abstract

2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in public health. According to news reporting originating from [...]

Published
2023

12. The Supply Of A Drug For Medical Use Of Valproic Acid To The Warehouse Of A State Customer For Social Security Of Citizens In Accordance With The List Of Groups Of The Population And Categories Of Diseases, With Outpatient Treatment Of Which Medicines And

Subjects
Social security -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Business, international
Abstract

Tenders are invited for the supply of a drug for medical use of valproic acid to the warehouse of a state customer for social security of citizens in accordance with [...]

Published
2022

13. Delivery Of A Drug For Medical Use Of Valproic Acid (1)

Subjects
Purchasing departments -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Business, international
Abstract

Tenders are invited for delivery of a drug for medical use of valproic acid (1) Major organization : PUBLIC PROCUREMENT DEPARTMENT OF THE TYUMEN REGION Address : 625003, Tyumen, Tyumen, [...]

Published
2022

14. Delivery Of Drugs For Medical Use Of Mnn Valproic Acid

Subjects
Purchasing departments -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Business, international
Abstract

Tenders are invited for delivery of drugs for medical use of mnn valproic acid Major organization : PUBLIC PROCUREMENT DEPARTMENT OF THE TYUMEN REGION Address : 625003, Tyumen, Tyumen, Tyumen [...]

Published
2022

16. Delivery Of Drugs For Medical Use Of Mnn Valproic Acid

Subjects
Purchasing departments -- Usage -- Health aspects, Valproic acid -- Usage, Divalproex -- Usage, Business, international
Abstract

Tenders are invited for delivery of drugs for medical use of mnn valproic acid Major organization : PUBLIC PROCUREMENT DEPARTMENT OF THE TYUMEN REGION Address : 625003, Tyumen, Tyumen, Tyumen [...]

Published
2022

17. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

Author

Cnaan, Avital, Glauser, Tracy A., Shinnar, Shlomo, Hirtz, Deborah G., Dlugos, Dennis, Masur, David, Clark, Peggy O., Capparelli, Edmund V., and Adamson, Peter C.

Subjects
Ethosuximide -- Usage, Ethosuximide -- Health aspects, Absence epilepsy -- Care and treatment, Lamotrigine -- Usage, Lamotrigine -- Health aspects, Divalproex -- Usage, Divalproex -- Health aspects, Valproic acid -- Usage, Valproic acid -- Health aspects
Abstract

The study aims to evaluate and compare the efficacy of the use of ethosuximide, valproic acid, and lamotrigine in the treatment of childhood absence epilepsy. The results indicate that ethosuximide and valproic acid are more effective, and that ethosuximide is associated with fewer adverse effects.

Published
2010

18. Valproic acid affects membrane trafficking and cell-wall integrity in fission yeast

Author

Miyatake, Makoto, Kuno, Takayoshi, Kita, Ayako, Katsura, Kosaku, Takegawa, Kaoru, Uno, Satoshi, Nabata, Toshiya, and Sugiura, Reiko

Subjects
Divalproex -- Usage, Divalproex -- Health aspects, Valproic acid -- Usage, Valproic acid -- Health aspects, Yeast fungi -- Research, Yeast fungi -- Genetic aspects, Biological sciences
Abstract

Valproic acid (VPA) is widely used to treat epilepsy and manic-depressive illness. Although VPA has been reported to exert a variety of biochemical effects, the exact mechanisms underlying its therapeutic effects remain elusive. To gain further insights into the molecular mechanisms of VPA action, a genetic screen for fission yeast mutants that show hypersensitivity to VPA was performed. One of the genes that we identified was [vps45.sup.+], which encodes a member of the Sec1/Muncl8 family that is implicated in membrane trafficking. Notably, several mutations affecting membrane trafficking also resulted in hypersensitivity to VPA. These include [ypt3.sup.+] and [ryh1.sup.+], both encoding a Rab family protein, and [apm1.sup.+], encoding the [micro]1 subunit of the adaptor protein complex AP-1. More importantly, VPA caused vacuolar fragmentation and inhibited the glycosylation and the secretion of acid phosphatase in wild-type cells, suggesting that VPA affects membrane trafficking. Interestingly, the cell-wall-damaging agents such as micafungin or the inhibition of calcineurin dramatically enhanced the sensitivity of wild-type cells to VPA. Consistently, VPA treatment of wild-type cells enhanced their sensitivity to the cell-wall-digesting enzymes. Altogether, our results suggest that VPA affects membrane trafficking, which leads to the enhanced sensitivity to cell-wall damage in fission yeast.

Published
2007

19. Supply Of Medicine (like 'tab. Chlorpromazine 50mg' And 'tab. Divalproex Sodium 500mg') For The Use Of Tufanganj Mental Hospital

Subjects
Phenothiazine -- Usage, Central nervous system depressants -- Usage, Psychiatric hospital care -- Usage, Valproic acid -- Usage, Psychiatric hospitals -- Usage, Divalproex -- Usage, Business, international
Abstract

Quotation are invited for Supply Of Medicine (Like 'Tab. Chlorpromazine 50Mg' And 'Tab. Divalproex Sodium 500Mg') For The Use Of Tufanganj Mental Hospital Opening date : 06 Feb 2021 Major [...]

Published
2021

20. Extracorporeal elimination in acute valproic acid poisoning

Author

Thanacoody, Ruben H.K.

Subjects
Hemodialysis -- Health aspects, Epilepsy -- Care and treatment, Poisoning -- Care and treatment, Divalproex -- Usage, Divalproex -- Health aspects, Valproic acid -- Usage, Valproic acid -- Health aspects, Environmental issues, Health, Pharmaceuticals and cosmetics industries
Published
2009

21. New Acute Myeloid Leukemia Study Results from University of Bergen Described (Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic ...)

Subjects
Oncology, Experimental -- Usage, Mortality -- Norway, Tretinoin -- Usage, Stem cells -- Usage, Valproic acid -- Usage, Divalproex -- Usage, Cancer -- Research, Health, University of Bergen
Abstract

2021 JUN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Researchers detail new data in acute myeloid leukemia. According to news originating from Bergen, Norway, [...]

Published
2021

22. Valproic acid for the treatment of myeloid malignancies

Author

Kuendgen, Andrea and Gattermann, Norbert

Subjects
Myelocytic leukemia -- Drug therapy, Myelocytic leukemia -- Research, Nonlymphoid leukemia -- Drug therapy, Nonlymphoid leukemia -- Research, Divalproex -- Usage, Valproic acid -- Usage, Drug therapy -- Patient outcomes, Drug therapy -- Research, Health
Published
2007

23. Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions

Author

Wassef, Adel A., Winkler, Diane E., Roache, Ann L., Abobo, Vivian Boma, Lopez, Lina M., Averill, John P., Mian, Ayesha I., and Overall, John E.

Subjects
Divalproex -- Research, Divalproex -- Usage, Valproic acid -- Research, Valproic acid -- Usage, Health, Psychology and mental health
Abstract

Objective: The authors examined clinical differences between divalproex sodium and generic immediate release valproic acid. Method: This 6-year prospective, quasi-experimental clinical trial compared the effectiveness and tolerability of divalproex and valproic acid. The dependent variables were length of hospital stay, rehospitalization rate, and adverse drug reactions in 9,260 psychiatric admissions. Results: Inpatients who initially received divalproex sodium had a 32.7% longer hospital stay and 3.8% higher readmission rate than did patients who initially received valproic acid. Initial treatment with divalproex prolonged length of stay by 30.3% in patients treated with divalproex and valproic acid during different admissions. After other variables were controlled by multiway analysis of variance, the hospital stay of patients who continued the initial medication was 15.2% longer (2.0 days) for divalproex than valproic acid. Switching medications was more common for valproic acid, partly because of study design. Medication intolerance occurred in approximately 6.4% more patients taking valproic acid than divalproex. However, switching from valproic acid to divalproex did not significantly prolong length of stay, over that for continuous divalproex, or increase the rehospitalization rate. Conclusions: Lower peak valproate concentrations with divalproex sodium may have enhanced tolerability but may also explain the lower effectiveness. Extendedrelease divalproex could lower effectiveness further and require higher doses. Thus, inpatients are better served by beginning with generic valproic acid and by changing to delayed-release divalproex only if intolerance occurs. This would save up to one-third of inpatient costs and twothirds of a billion dollars yearly in medication costs.

Published
2005

24. Ethosuximide in childhood absence epilepsy - older and better

Author

Vining, Eileen P.G.

Subjects
Ethosuximide -- Usage, Ethosuximide -- Health aspects, Ethosuximide -- Comparative analysis, Absence epilepsy -- Care and treatment, Divalproex -- Usage, Divalproex -- Health aspects, Divalproex -- Comparative analysis, Valproic acid -- Usage, Valproic acid -- Health aspects, Valproic acid -- Comparative analysis, Lamotrigine -- Usage, Lamotrigine -- Health aspects, Lamotrigine -- Comparative analysis
Abstract

Results of a study to evaluate and compare the efficacy of the use of ethosuximide, valproic acid, and lamotrigine in the treatment of childhood absence epilepsy have revealed that ethosuximide and valproic acid are more effective, and that ethosuximide is associated with fewer adverse effects. The study has shown that the oldest of the three therapies was the most effective.

Published
2010

25. Use of naloxone in valproate overdose

Author

Sanaei-Zadeh, Hossein

Subjects
Drugs -- Overdose, Naloxone -- Usage, Valproic acid -- Usage, Divalproex -- Usage, Health
Abstract

Byline: Hossein. Sanaei-Zadeh Sir, I read with interest, the recent case presentation by Nasa et al . regarding the effectiveness of hemodialysis in a case of severe valproate overdose published [...]

Published
2012

26. Psychiatric use and utility of divalproex sodium in Connecticut prisons

Author

Kamath, Jayesh, Temporini, Humberto D., Quarti, Susan, Zhang, Wanli, Pagano, Karen L., DeMartinis, Nicholas, and Trestman, Robert L.

Subjects
Divalproex -- Usage, Divalproex -- Patient outcomes, Valproic acid -- Usage, Valproic acid -- Patient outcomes, Correctional institutions -- Management, Prisoners -- Psychological aspects, Prisoners -- Care and treatment, Company business management, Health, Law, Psychology and mental health
Abstract

The investigation of the on- and off use of divalproex sodium (DVX) use in prisons in Connecticut Department of Correction and to evaluate its impact on clinical outcomes is presented. Results indicated that there was a high off-label utilization of DVX in prisons in Connecticut and clinical improvement occured when impulsive aggression was the target symptom.

Published
2008

27. Divalproex used to treat impulsive aggression

Author

Coccaro, Kavoussi RJ

Subjects
Aggressiveness (Psychology) -- Drug therapy -- Usage, Valproic acid -- Usage, Divalproex -- Usage, Hostility (Psychology) -- Drug therapy -- Usage, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health
Abstract

Kavoussi RJ, Coccaro EF: Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. Journal of Clinical Psychiatry 1998; 59:676-680. For reprints, contact Richard J. Kavoussi, M.D., Department of [...]

Published
1999

28. Absence seizures: ethosuximide versus valproic acid versus lamotrigine

Subjects
Seizures (Medicine) -- Drug therapy, Seizures (Medicine) -- Health aspects, Ethosuximide -- Usage, Ethosuximide -- Health aspects, Divalproex -- Usage, Divalproex -- Health aspects, Valproic acid -- Usage, Valproic acid -- Health aspects, Lamotrigine -- Usage, Lamotrigine -- Health aspects
Published
2010

29. N Engl J Med: Valproate in Pregnancy Linked to Lower IQ in Children

Subjects
Emory University -- Research, Pregnant women -- Health aspects, Divalproex -- Usage, Valproic acid -- Usage, Children -- Health aspects
Abstract

The use of valproate in pregnant women with epilepsy is associated with a higher risk of impaired cognitive function in their children at age three, according to researchers at Emory [...]

Published
2009

30. Studies from Scottish National Blood Transfusion Service Further Understanding of Nucleoproteins (Use of IL3 and chromatin-modifying reagents valproic acid and 5-aza-2'-deoxycytidine to affect mobilized peripheral blood CD34+ cell fate decisions)

Subjects
Chromatin, Blood transfusion, Valproic acid -- Usage, Chemical tests and reagents -- Usage, Divalproex -- Usage, Health
Abstract

By a News Reporter-Staff News Editor at Blood Weekly -- Investigators discuss new findings in Proteins. According to news reporting out of Edinburgh, United Kingdom, by NewsRx editors, research stated, [...]

Published
2014

31. Valproic acid-induced cognitive impairment in an elderly man

Subjects
Seizures (Medicine) -- Care and treatment, Aged -- Care and treatment -- Usage, Valproic acid -- Usage, Divalproex -- Usage, Health, Psychology and mental health, Seniors
Abstract

Patient: Male, 81 y/o Medications: valproic acid (Depakene, Depakote), lamotrigine (Lamictal) Case: An elderly man presented with generalized tonic-clonic seizures. A brain-computed tomography (CT) scan revealed vascular hypodensities in the [...]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results